Diagnostic accuracy of serum Ca 19-9 in predicting malignancy in patients undergoing pancreatic resection.

被引：0
|
作者：
Bekaii-Saab, TS [1 ]
Cowgill, SM [1 ]
Burak, WE [1 ]
Melvin, WS [1 ]
Ellison, EC [1 ]
Muscarella, P [1 ]
机构：
[1] Ohio State Univ, Columbus, OH 43210 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4210
引用
收藏
页码：365S / 365S
页数：1
相关论文
共 50 条
  • [31] Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
    Naru Kondo
    Yoshiaki Murakami
    Kenichiro Uemura
    Yasuo Hayashidani
    Takeshi Sudo
    Yasushi Hashimoto
    Akira Nakashima
    Ryutaro Sakabe
    Norifumi Shigemoto
    Yasushi Kato
    Hiroki Ohge
    Taijiro Sueda
    Annals of Surgical Oncology, 2010, 17 : 2321 - 2329
  • [32] The diagnostic importance of CEA and CA 19-9 for the early diagnosis of pancreatic carcinoma
    Nazli, O
    Bozdag, AD
    Tansug, T
    Kir, R
    Kaymak, E
    HEPATO-GASTROENTEROLOGY, 2000, 47 (36) : 1750 - 1752
  • [33] Marked elevation of CA 19-9 not associated with malignancy
    El Hajj, I. I.
    Sanders, M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 151 - 152
  • [34] Serum CA 19-9 levels in patients with endometriosis.
    Choi, YM
    Sohn, YK
    Kim, SH
    Kim, JG
    Moon, SY
    Lee, JY
    FERTILITY AND STERILITY, 2002, 77 (02) : S35 - S35
  • [35] Correlation Analysis of Baseline Serum CA 19-9, CEA, and CA 125 in Patients With Advanced Pancreatic Cancer
    Deng, G.
    Yan, H.
    Guo, Z.
    Dai, G.
    PANCREAS, 2020, 49 (10) : 1406 - 1406
  • [36] The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates
    Poruk, K. E.
    Gay, D. Z.
    Brown, K.
    Mulvihill, J. D.
    Boucher, K. M.
    Scaife, C. L.
    Firpo, M. A.
    Mulvihill, S. J.
    CURRENT MOLECULAR MEDICINE, 2013, 13 (03) : 340 - 351
  • [37] CA 19-9 and pancreatic carcinoma, a revival?
    Ducreux, Michel
    Boige, Valerie
    Malka, David
    ONKOLOGIE, 2007, 30 (1-2): : 12 - 13
  • [38] Serum CA 19-9 as a Biomarker for Pancreatic Cancer-A Comprehensive Review
    Ballehaninna U.K.
    Chamberlain R.S.
    Indian Journal of Surgical Oncology, 2011, 2 (2) : 88 - 100
  • [39] Serum CA 19-9 and CEA Levels as a Prognostic Factor in Pancreatic Adenocarcinoma
    Lee, Kyong Joo
    Yi, Seung Woo
    Chung, Moon Jae
    Park, Seung Woo
    Song, Si Young
    Chung, Jae Bock
    Park, Jeong Youp
    YONSEI MEDICAL JOURNAL, 2013, 54 (03) : 643 - 649
  • [40] Serum CA 19-9 as Predictor in Preoperative Parameters for Resectable Pancreatic Adenocarcinoma
    Itakura, J.
    Watanabe, M.
    Hosomura, N.
    Amemiya, H.
    Kawaida, H.
    Okamoto, H.
    Kohno, H.
    Ichikawa, D.
    PANCREAS, 2018, 47 (10) : 1395 - 1395
12345